Orthofix Medical Inc.
OFIX
$9.93
$0.060.61%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.58% | 1.97% | 4.59% | 2.27% | 2.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.58% | 1.97% | 4.59% | 2.27% | 2.67% |
| Cost of Revenue | -9.73% | 5.07% | -7.22% | -0.44% | 3.19% |
| Gross Profit | 7.08% | 0.67% | 9.97% | 3.55% | 2.42% |
| SG&A Expenses | 1.38% | 0.20% | 13.84% | 1.70% | 0.98% |
| Depreciation & Amortization | -29.52% | -29.46% | -31.44% | -10.33% | 0.76% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.56% | -0.54% | 4.49% | -0.26% | 1.64% |
| Operating Income | 49.64% | 63.17% | -3.27% | 23.22% | 5.33% |
| Income Before Tax | 60.04% | 92.62% | 16.42% | 56.05% | -48.24% |
| Income Tax Expenses | -92.30% | 105.32% | -29.03% | -113.10% | 12.93% |
| Earnings from Continuing Operations | 60.62% | 92.38% | 16.77% | 57.90% | -47.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 60.62% | 92.38% | 16.77% | 57.90% | -47.40% |
| EBIT | 49.64% | 63.17% | -3.27% | 23.22% | 5.33% |
| EBITDA | 111.47% | -36.36% | -990.57% | 119.55% | 4.36% |
| EPS Basic | 61.85% | 92.62% | 19.45% | 59.47% | -41.96% |
| Normalized Basic EPS | 35.68% | 78.54% | 11.07% | 50.76% | 15.28% |
| EPS Diluted | 61.62% | 92.40% | 19.45% | 59.09% | -41.96% |
| Normalized Diluted EPS | 35.68% | 78.54% | 11.07% | 50.76% | 15.28% |
| Average Basic Shares Outstanding | 3.22% | 3.36% | 3.32% | 3.90% | 3.83% |
| Average Diluted Shares Outstanding | 3.22% | 3.36% | 3.32% | 3.90% | 3.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |